Search clinical trials for: Adderall XR ®

Total 14208 results

NYU Langone Health

Completed

A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall

Attention Deficit Hyperactivity Disorder

United States
London Health Sciences Centre

Completed

Adderall XR and Processing Speed in Multiple Sclerosis (MS)

Multiple Sclerosis | Cognitive Impairment | Impaired Processing Speed

Canada
Sarah Morrow

Recruiting

Adderall XR and Cognitive Impairment in MS

Multiple Sclerosis

Canada
Baystate Medical Center
National Institute of Mental Health (NIMH)

Completed

Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With ADHD

Attention Deficit Disorder With Hyperactivity
University of California, Los Angeles

Enrolling by invitation

Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder (Stimulant-rTMS)

Major Depressive Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence (TACT)

Cocaine Dependence

United States
Eisai Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years

Obesity

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence (CAMP)

Cocaine Dependence | Adult Attention Deficit Hyperactivity Disorder

United States
Boston Children's Hospital

Recruiting

Biomarkers of ADHD Treatment Response (BAT)

ADHD

United States
University of South Florida
National Cancer Institute (NCI)

Terminated

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Depression | Unspecified Childhood Solid Tumor, Protocol Specific | Neurotoxicity

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions

Fed

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

Fasting

United States
Seattle Children's Hospital
Novartis

Completed

Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR

Attention Deficit Hyperactivity Disorder

United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Completed

GXR RM (Glucophage® Extended Release Reduced Mass) 500 Milligram (mg) Korea Bioequivalence (BE) Study

Healthy

Korea, Republic of
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Completed

GXR RM China BE Study (Darmstadt - Jiangsu)

Healthy

Germany
Mayo Clinic

Completed

Cardiovascular Effects of Adderall in Healthy Adults.

Cardiovascular System | Hemodynamics

United States
UCB Pharma

Completed

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Epilepsy

Brazil, Finland, India, Mexico, Russian Federation, South Africa, Ukraine
University of Alabama at Birmingham

Not yet recruiting

The Role of Expectancy for Cognitive Enhancement in College Students Using Prescription Stimulants Nonmedically

Expectations | Prescription Stimulants | Deception
Joint Stock Company "Farmak"

Completed

Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (TACT2)

Cocaine Dependence

United States
University of Wyoming

Recruiting

Acute Effects of Stimulant Medication in College Students With ADHD

Attention Deficit Hyperactivity Disorder | Mood | Working Memory | Stimulant Use | Change in Sustained Attention

United States
Joint Stock Company "Farmak"

Completed

Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
Joint Stock Company "Farmak"

Completed

Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
Shire

Completed

Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC

Healthy Volunteers

United States
Massachusetts General Hospital
Harvard Medical School (HMS and HSDM)

Terminated

Stimulant Enhancement of Well-Being Therapy for Depression

Major Depressive Disorder

United States
Shire

Completed

Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD

ADHD

United States
Shire

Completed

Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

ADHD

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder (MJ-ADHD)

Attention-deficit/Hyperactivity Disorder | Cannabis Use Disorder

United States
Shire

Completed

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Lily Hechtman

Unknown

Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Canada
Yale University
Veloxis Pharmaceuticals

Recruiting

Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.

Kidney Transplant; Complications

United States
Universitaire Ziekenhuizen KU Leuven

Recruiting

Journey Bicruciate Stabilized (BCS) Design and Legion Posterior Stabilized (PS) Design; Comparative Study (BCR)

Primary Total Knee Arthroplasty

Belgium
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)

Diabetes Mellitus
New River Pharmaceuticals

Completed

NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

Attention Deficit Disorder With Hyperactivity
Allergan

Completed

Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy Subjects

Healthy

United States
UCB Pharma

Completed

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Epilepsy

United States, Poland, Mexico, Russian Federation
AstraZeneca

Completed

Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects

Type 2 Diabetes Mellitus

United Kingdom
Supernus Pharmaceuticals, Inc.

Completed

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Epilepsy

United States
Joint Stock Company "Farmak"

Completed

Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers

Pharmacokinetics

Czechia
AstraZeneca

Terminated

Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM

Type 2 Diabetes Mellitus

United States
Rhodes Pharmaceuticals, L.P.

Completed

Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD (PK003)

Attention-Deficit/Hyperactivity Disorder

United States
Coopervision, Inc.

Completed

Multicenter Dispensing Study of Biofinity Lenses in Extended Range

Myopia | Hyperopia

United States, Canada
Envisia Therapeutics

Completed

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

Glaucoma and Ocular Hypertension

United States
Merck Sharp & Dohme LLC

Completed

Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)

Type 2 Diabetes Mellitus
FUSMobile Inc.

Active, not recruiting

Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain

Facet Syndrome of Lumbar Spine

Canada
Upsher-Smith Laboratories

Recruiting

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

Migraine Disorders

United States
Swiss Federal Institute of Sport Magglingen

Unknown

Validation Sonic Bone's Ultrasound System for Bone Age Assessment (BAUS)

Bone Age Assessment

Switzerland
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Sequenced Behavioral and Medication Intervention for Cocaine Dependence

Cocaine Dependence

United States
Meir Medical Center

Unknown

Clinical and Radiologic Follow up of Subchondral Fractures of the Glenoid

Subchondral Fractures of the Glenoid
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR)

Unknown

Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Canada

3

Subscribe